Skip to main content

WakeMed Among First in U.S. to Treat Heart Attack Patients with Supersaturated Oxygen

WakeMed is the second hospital in the U.S. to treat a patient with a potentially breakthrough treatment that uses Supersaturated Oxygen (SSO2) Therapy to reduce damage to the heart muscle after a heart attack.

This groundbreaking trial – called the IC-HOT study – offers a new intervention option beyond angioplasty and stenting for heart attacks, which may further improve outcomes for patients.

Dr. Frances Wood, a board-certified interventional and structural cardiologist with WakeMed Heart & Vascular Physicians, administered the SSO2 Therapy to a STEMI, or severe heart attack, patient on February 23 at WakeMed Heart Center.

The lack of oxygen and the extent of heart muscle damage following a severe heart attack can carry a poorer prognosis for patients,” said Dr. Wood. “This important study of SSO2 Therapy may provide physicians with an additional intervention to repair the heart muscle, further improve outcomes and help restore quality of life for our heart attack patients.

You can read the full press release here.